d41586-024-00080-1
d41586-024-00080-1
d41586-024-00080-1
Pavlopoulos et al. report, and microbes called One Health Ruhr, University Alliance Ruhr, The authors declare no competing interests.
Asgardarchaeota, as presented by Rodríguez Department of Chemistry at University of This article was published online on 30 January 2024.
del Río and colleagues. The latter are a group
of microorganisms called archaea that are
Cancer
closely related to the first ancestor of eukar-
Fragmented lipid
leads to cell rupture
HMG-CoA
and ferroptosis Radical
Intact
phospholipid
Zymosterol Phospholipid 7-DHC
ER
Mitochondrion
Figure 1 | A molecule that can help to halt cell death by ferroptosis. A membrane and in another type of organelle, known as mitochondria. 7-DHC is
hallmark of ferroptosis is lipid modification (oxidation) mediated by iron and generated in the pathway (not all steps of which are shown) that converts the
molecules called free radicals, such as reactive oxygen species (ROS). Oxidation molecule HMG-CoA to cholesterol through a route that includes the molecules
of lipids, particularly of those called phospholipids, in cellular membranes zymosterol and lathosterol and depends on enzymes such as EBP, SC5D
can kill cells. Freitas et al.1 and Li et al.2 report a previously unknown natural and DHCR7. When radicals attack phospholipids, the lipid is oxidized and it
inhibitor of ferroptosis. This molecule, 7-dehydrocholesterol (7-DHC), is made fragments. 7-DHC absorbs radicals, counteracting their ability to trigger lipid
in an organelle called the endoplasmic reticulum (ER) and found on the cell oxidation and ferroptosis.
The discovery of a natural inhibitor of Building on their initial findings, Li and col- is validated in clinical testing. However,
ferroptosis has profound therapeutic impli- leagues examined 7-DHC’s role in metastasis. previous research8,9 indicates that excessive
cations. By modulating the levels of 7-DHC, The authors hypothesized that before spread- levels of 7-DHC and the products arising from
there is the potential to either induce or ing to distant organs, cancer cells need to modifications (oxidation) of this molecule
counteract ferroptosis. Investigating the endure environments that have a condition might be detrimental, particularly to neu-
role of 7-DHC in human cancers, Freitas and (oxidative stress) that predisposes the cells ronal and retinal cells. Thoroughly examining
colleagues observed that 9.8% of individu- to ferroptosis. Li et al. used a combination of the implications for brain and eye health will
als studied who had Burkitt’s lymphoma had approaches to investigate this. These included be crucial before incorporating any 7-DHC-
mutations in the DHCR7 gene, which encodes deleting the DHCR7 gene, inhibiting DHCR7 based therapeutic strategies into standard
the corresponding enzyme. The authors note with the drug AY9944, pretreating melanoma clinical practice.
a less-frequent occurrence of such mutations cancer cells with 7-DHC to elevate 7-DHC levels
in people who have a brain cancer called and using TASIN-30 to hinder 7-DHC synthe- Donna D. Zhang is in the Center for
neuroblastoma. sis. These approaches establish that 7-DHC Inflammation Science and Systems Medicine,
The deletion of DHCR7 by Li and colleagues The Herbert Wertheim University of Florida
increased 7-DHC levels, bolstering the “Harnessing this new Scripps Institute for Biomedical Innovation
resistance of neuroblastoma cancer cells and Technology, Jupiter, Florida 33458, USA.
to ferroptosis when tested in vitro. In vivo
understanding with e-mail: zhangd1@ufl.edu
experiments in mice showed that these engi- available tools holds the
neered human neuroblastoma cells evaded potential to transform
ferroptotic death, leading to faster tumour
growth, increased tumour spread (metastasis)
clinical treatments.”
and decreased survival time compared with
results from mice in which the transplanted can fortify melanoma cells, enhancing their
cells expressed DHCR7. survival and accelerating metastasis.
Li et al. present evidence of the effect of Using a mouse model of tissue injury, Li and
manipulating 7-DHC levels. They report that colleagues demonstrated that the accumula-
inhibiting 7-DHC synthesis by targeting an tion of 7-DHC could be amplified by inhibiting
enzyme called EBP in the cholesterol-synthesis DHCR7, achieved through pre-injury injections
pathway with the molecule TASIN-30 induced of DHCR7 inhibitors. This intervention effec-
1. Freitas, F. P. et al. Nature 626, 401–410 (2024).
ferroptosis. This led to the suppression of tively shielded against injury by preventing 2. Li, Y. et al. Nature 626, 411–418 (2024).
tumour growth in vivo when human cancer ferroptotic death of kidney cells. 3. Dixon, S. J. et al. Cell 149, 1060–1072 (2012).
cells with high levels of 7-DHC were injected The discovery of 7-DHC’s role in prevent- 4. Stockwell, B. R. et al. Cell 171, 273–285 (2017).
5. Galy, B., Conrad, M. & Muckenthaler, M. Nature Rev. Mol.
into mice. It is notable that this cell-death sup- ing ferroptosis is a key leap forwards in this Cell Biol. 25, 133–155 (2024).
pression occurred even in the absence of other area. The therapeutic potential of the finding 6. Anandhan, A. et al. Sci. Adv. 9, eade9585 (2023).
ferroptosis inducers besides TASIN-30, under- is strikingly evident. Given the availability 7. Conrad, M., Angeli, J. P. F., Vandenabeele, P. & Stockwell,
B. R. Nature Rev. Drug Discov. 15, 348–366 (2016).
scoring the key role of 7-DHC in providing pro- of drugs already in clinical use to target 8. Xu, L. et al. Neurobiol. Dis. 45, 923–929 (2012).
tection against cell death for certain cancer DHCR7, harnessing this new understanding 9. Pfeffer, B. A., Xu, L., Porter, N. A., Rao, S. R. & Fliesler, S. J.
types. This protective mechanism makes these with available tools holds the potential to Exp. Eye Res. 145, 297–316 (2016).
cancer cells susceptible to drugs that inhibit transform clinical treatments for conditions The author declares no competing interests.
7-DHC production. influenced by ferroptosis, if this approach This article was published online on 31 January 2024.